Proteomics solutions
Protein biomarker detection and quantification services and multiplexed immunoassay services powered by various cutting-edge technologies such as Olink® and Quanterix®.
OUR TEAM
A powerful combination of scientific expertise and cutting-edge platforms allowing us to deliver customized proteomics solutions addressing the diverse and evolving needs of our clients.
OUR CAPABILITIES
Panel customization and validation | Absolute quantification with multiplexed immunoassays | Ultra-sensitive protein biomarker detection
EXPLORE OUR SERVICES
Large-protein screening using Olink® technology
Firalis Molecular Precision positions itself as a certified Olink® Technology service provider and as one of the world’s first service providers.
Our experts leverage the Olink® Signature Q100 platform under GCLP conditions with the Flex and Target 48 panels. Target 96 and Explore panels are also leveraged for our services.
Our services play a pivotal role in drug target discovery, elucidating drug MoA, and conducting biomarker screening.
Absolute biomarker quantification with multiplexed immunoassays
With a repertoire of over +1000 validated assays, our immunoassay services feature cutting-edge technologies, including Bio-rad Luminex® BioPlex 200™, MSD Meso Sector S 600mm and Protein Simple ELLA™ for protein biomarker absolute quantification.
Specializing in cytokines testing, surrogate biomarkers, and biomarker validation, our services cater to diverse therapeutic areas, including immunology, oncology, cardiology, and neurology.
Ultra-sensitive biomarker detection systems
Our experts leverage the Quanterix SR-X™, powered by the Simoa® bead technology, and Quanterix SP-X™ technologies.
These platforms, with applicability for immuno-oncology, neurological and inflammatory biomarkers, redefine protein detection and quantification, enabling researchers to explore ultra-low concentrations with sensitivity and precision.
